Atlas Trials

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Clinical trial NCT00942331 · COMPLETED

Trial details

NCT number
NCT00942331
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Urothelial CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Prostate CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial CarcinomaMetastatic Urethral Urothelial CarcinomaMetastatic Urothelial CarcinomaStage IV Bladder Urothelial Carcinoma AJCC v7Stage IV Prostate Cancer AJCC v7Stage IV Renal Pelvis Cancer AJCC v7Stage IV Ureter Cancer AJCC v7Stage IV Urethral Cancer AJCC v7
Start date
2009-07-15
Primary completion
2018-11-02
Enrollment
506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.